Beretta L - Search Results

1

Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.

Lee NP, Chen L, Lin MC, Tsang FH, Yeung C, Poon RT, Peng J, Leng X, Beretta L, Sun S, Day PJ, Luk JM. Lee NP, et al. Among authors: beretta l. J Proteome Res. 2009 Mar;8(3):1293-303. doi: 10.1021/pr800637z. J Proteome Res. 2009. PMID: 19161326 Free PMC article.

2

Proteomics for hepatocellular carcinoma marker discovery.

Chignard N, Beretta L. Chignard N, et al. Among authors: beretta l. Gastroenterology. 2004 Nov;127(5 Suppl 1):S120-5. doi: 10.1053/j.gastro.2004.09.025. Gastroenterology. 2004. PMID: 15508075 Review.

3

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST. Yi X, et al. Among authors: beretta l. Mol Cell Proteomics. 2008 Feb;7(2):315-25. doi: 10.1074/mcp.M700116-MCP200. Epub 2007 Oct 14. Mol Cell Proteomics. 2008. PMID: 17934217 Free article.

4

Comparative analysis of the liver and plasma proteomes as a novel and powerful strategy for hepatocellular carcinoma biomarker discovery.

Beretta L. Beretta L. Cancer Lett. 2009 Dec 1;286(1):134-9. doi: 10.1016/j.canlet.2009.01.025. Epub 2009 Feb 15. Cancer Lett. 2009. PMID: 19232462 Free PMC article. Review.

5

Identification of osteopontin as a novel marker for early hepatocellular carcinoma.

Shang S, Plymoth A, Ge S, Feng Z, Rosen HR, Sangrajrang S, Hainaut P, Marrero JA, Beretta L. Shang S, et al. Among authors: beretta l. Hepatology. 2012 Feb;55(2):483-90. doi: 10.1002/hep.24703. Epub 2011 Dec 19. Hepatology. 2012. PMID: 21953299 Free PMC article.

6

Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma.

Muir K, Hazim A, He Y, Peyressatre M, Kim DY, Song X, Beretta L. Muir K, et al. Among authors: beretta l. Cancer Res. 2013 Aug 1;73(15):4722-31. doi: 10.1158/0008-5472.CAN-12-3797. Epub 2013 Jun 7. Cancer Res. 2013. PMID: 23749645 Free PMC article.

7

Proteomics for the early detection and treatment of hepatocellular carcinoma.

Feng JT, Shang S, Beretta L. Feng JT, et al. Among authors: beretta l. Oncogene. 2006 Jun 26;25(27):3810-7. doi: 10.1038/sj.onc.1209551. Oncogene. 2006. PMID: 16799622 Review.

8

HUPO's effort to define the liver proteome.

Beretta L. Beretta L. J Proteome Res. 2010 Feb 5;9(2):637-8. doi: 10.1021/pr100011s. J Proteome Res. 2010. PMID: 20092292 Free PMC article. No abstract available.

9

Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.

da Costa AN, Plymoth A, Santos-Silva D, Ortiz-Cuaran S, Camey S, Guilloreau P, Sangrajrang S, Khuhaprema T, Mendy M, Lesi OA, Chang HK, Oh JK, Lee DH, Shin HR, Kirk GD, Merle P, Beretta L, Hainaut P. da Costa AN, et al. Among authors: beretta l. Int J Cancer. 2015 Jan 1;136(1):172-81. doi: 10.1002/ijc.28953. Epub 2014 May 15. Int J Cancer. 2015. PMID: 24803312 Free PMC article.

10

Mammalian target of rapamycin activation impairs hepatocytic differentiation and targets genes moderating lipid homeostasis and hepatocellular growth.

Parent R, Kolippakkam D, Booth G, Beretta L. Parent R, et al. Among authors: beretta l. Cancer Res. 2007 May 1;67(9):4337-45. doi: 10.1158/0008-5472.CAN-06-3640. Cancer Res. 2007. PMID: 17483347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

647 results

Search Page

Filters